The pharmacodynamics and pharmacokinetics of cisatracurium in patients with renal or hepatic failure

Jennifer M. Hunter*, Andre De Wolf

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Two studies were performed to compare the pharmacodynamics and pharmacokinetics of cisatracurium in healthy control patients and in patients with end-stage renal disease undergoing elective non-transplant surgery or end-stage liver disease undergoing liver transplantation. Minor differences were detected in the pharmacokinetics of cisatracurium in the healthy control patients and in the patients with renal or liver disease. These differences were associated with small changes in the time to onset of neuromuscular blockade, but were not associated with clinically relevant differences in the recovery profile of cisatracurium. No adverse effects were observed following the administration of cisatracurium to these patient populations.

Original languageEnglish (US)
Pages (from-to)S42-S46
JournalCurrent opinion in anaesthesiology
Volume9
Issue numberSUPPL. 1
DOIs
StatePublished - 1996

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'The pharmacodynamics and pharmacokinetics of cisatracurium in patients with renal or hepatic failure'. Together they form a unique fingerprint.

Cite this